[144] Bausch Health Companies Inc SEC Filing

Rhea-AI Filing Summary

Bausch Health Companies Inc (BHC) filed a Form 144 reporting a proposed sale of 13,370 common shares held at Fidelity Brokerage Services. The filing lists an aggregate market value of $97,734.70 and shows approximately 369,790,319 shares outstanding. The proposed sale is scheduled around 09/08/2025. The shares were acquired on 09/05/2025 through restricted stock vesting and were paid as compensation on the same date. The filer reports no other sales in the past three months and attests to the absence of undisclosed material adverse information.

Positive

• Timely regulatory disclosure of a proposed insider sale including broker, quantity, value, and planned sale date
• Securities originated from restricted stock vesting, indicating the transfer relates to compensation rather than an external purchase

Negative

• Insider proposes to sell 13,370 shares, which could be perceived negatively by some investors despite being small relative to outstanding shares

Insights

Financial Analyst

TL;DR Routine insider sale from vested restricted stock; transaction size is small relative to outstanding shares.

The filing documents a planned sale of 13,370 common shares valued at $97,734.70, representing a de minimis portion of the company's roughly 369.8 million shares outstanding. The shares originated from restricted stock vesting and were treated as compensation, suggesting this is a routine liquidity event rather than a strategic divestiture. No other sales in the prior three months were reported, and the filer affirms no undisclosed material information. From a financial-significance perspective, the transaction is unlikely to materially affect market valuation or ownership structure.

Corporate Governance Expert

TL;DR Compliance-focused disclosure; standard attestation included.

The Form 144 includes the expected attestation that the seller is unaware of undisclosed material adverse information and notes the transaction stems from restricted stock vesting paid as compensation. This aligns with standard insider reporting and Rule 144 procedures. The filing provides the broker name and planned sale date, supporting transparency. Given the small absolute size and the fact that acquisition was via compensation, this appears to be routine executive or employee liquidity rather than a signal of governance concerns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	13370	97734.70	369790319	09/08/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	09/05/2025	Restricted Stock Vesting	Issuer			13370	09/05/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did BHC report in the Form 144?

The filing reports a proposed sale of 13,370 common shares via Fidelity Brokerage Services with an aggregate market value of $97,734.70 and an approximate sale date of 09/08/2025.

How were the shares acquired that are to be sold?

The shares were acquired on 09/05/2025 through restricted stock vesting and the payment was recorded as compensation on the same date.

Does the Form 144 indicate other sales in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months by the person for whose account the securities are to be sold.

Who is the broker handling the proposed sale?

The broker listed is Fidelity Brokerage Services LLC located at the address shown in the filing.

What does the filer attest regarding material information?

The filer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.